Previous 10 | Next 10 |
BATON ROUGE, La., July 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2022. Three-Month Periods Ended June 30, 2022 and 2021 Net service revenue decreased $6.3 milli...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
UnitedHealth’s ongoing acquisition of LHC Group is an interesting merger arbitrage setup, potentially offering an annualized return of 10%. The spread has recently widened as the transaction has attracted the FTC’s attention. The merger still seems likely to close - ...
Enhabit appears to be significantly undervalued compared to peers in the same line of business. On an absolute basis, Enhabit looks cheap compared to its future cash flows. As a recent spinoff, Enhabit has come under non-fundamental selling pressure. Thesis Enhabit, ...
BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company wi...
Launching its coverage on Amedisys ( NASDAQ: AMED ) and Addus HomeCare ( ADUS ), Stifel issues a contrasting view on the two home health care companies after the Centers for Medicare and Medicaid Services (CMS) proposed cuts to Medicare home health rates last week. I...
HOUSTON and NASHVILLE, Tenn., June 24, 2022 (GLOBE NEWSWIRE) -- Memorial Hermann Health System is pleased to announce a new partnership with the nation's leading high-acuity home care provider Contessa, an Amedisys company (NASDAQ: AMED), to deliver home-based medical, rehabilitation an...
Amedisys (NASDAQ:AMED) stock fell ~13% on June 21 after Bank of America downgraded the stock to Underperform from Neutral with a price target of $102, from $145, following Centers for Medicare and Medicaid Services' (CMS) proposed cut to Medicare home health rates. Bofa Analyst Joanna Gajuk n...
Gainers: Convey Health Solutions CNVY +139%. Valneva VALN +87%. Clovis Oncology (CLVS) +34%. Innate Pharma (IPHA) +28%. Lexaria Bioscience (LEXX) +20%. Losers: ACADIA Pharmaceuticals ACAD -34%. Comera Life Sciences Holdings (CMRA) -17%. ...
Gainers: AN2 Therapeutics (ANTX) +7%. Design Therapeutics (DSGN) +6%. Edgio (EGIO) +5%. Humacyte (HUMA) +5%. Rhythm Pharmaceuticals (RYTM) +5%. Losers: Swvl Holdings (SWVL) -10%. Amedisys (AMED) -8%. Lilium (LILM) -5%. Centessa Pharmaceuticals (CNTA) -5%. KLX Energy Services Holding...
News, Short Squeeze, Breakout and More Instantly...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...
2024-05-27 23:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-08 00:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...